Aging Disrupts the Wound-Healing Senescence Program That Young Skin Depends On
New research reveals aged mice lack the beneficial senescent fibroblasts that drive ECM repair, explaining why older wounds heal slower.
Summary
Researchers at Boston University discovered that young skin relies on a transient population of senescent fibroblasts to heal wounds efficiently. These cells, marked by p16, p21, and SA-β-galactosidase, appear briefly after injury and produce extracellular matrix proteins that rebuild tissue. In aged mice, this beneficial senescence response was significantly blunted — fewer senescent fibroblasts appeared, and those that did shifted from a pro-healing ECM-remodeling function toward a pro-inflammatory state. Single-cell RNA sequencing of day-6 wounds confirmed this qualitative and quantitative deficit. The findings were corroborated in human wound tissue from young donors. This dual failure — too few beneficial senescent cells, and those present behaving harmfully — helps explain the chronic wound burden seen in older adults.
Detailed Summary
Chronic wounds in older adults represent a growing clinical crisis, yet the cellular mechanisms underlying age-related healing failure remain incompletely understood. This study from Boston University's Division of Plastic and Reconstructive Surgery investigated whether aging disrupts the transient, beneficial cellular senescence response that normally supports wound repair in young organisms. The central hypothesis was that aged skin fails to mount an adequate acute senescence program after injury, contributing to delayed closure.
The researchers created 1-cm full-thickness excisional dorsal skin wounds in young (2-month-old) and aged (24-month-old) male C57BL/6 mice, monitoring closure at days 6, 12, 18, and 24 (at least 5 animals per group per timepoint). Wound tissue was analyzed by qPCR, Western blotting, ELISA, immunostaining for p16, p21, and SA-β-galactosidase, and single-cell RNA sequencing (scRNA-seq) of day-6 wound cells pooled from n=3 mice per age group. Human wound scRNA-seq data (GSE241132) from young donors were also analyzed for cross-species validation.
Aged mice showed significantly delayed wound closure compared to young controls across all timepoints. At the molecular level, young wound tissue exhibited a robust transient upregulation of senescence markers — p16, p21, p53, and SA-β-galactosidase — peaking around day 6 and resolving by day 18–24. This response was markedly attenuated in aged wounds. SASP factors including IL-6, MCP-1/CCL2, MMP-3, MMP-8, MMP-9, TNF, and TGF-β1 were similarly elevated transiently in young wounds but blunted in aged tissue. Collagen gene expression (Col1a1, Col1a2, Col3a1) was also significantly reduced in aged wounds, consistent with impaired ECM remodeling.
scRNA-seq analysis of day-6 wound cells identified a distinct population of p16+/p21+/Ki67− senescent fibroblasts in young mice. Gene set enrichment analysis (GSEA) showed this population was strongly enriched for ECM organization, collagen fibril assembly, and wound healing pathways — a pro-reparative transcriptional signature. CellChat intercellular communication analysis revealed robust signaling from these senescent fibroblasts to other wound cell types in young mice. In aged wounds, this senescent fibroblast population was numerically reduced, and the cells that were present showed a qualitative functional shift: enrichment moved away from ECM remodeling toward pro-inflammatory pathways, representing a detrimental rather than reparative phenotype. Human scRNA-seq data from young donor wounds corroborated the existence of this p16+/p21+/Ki67− pro-healing senescent fibroblast population.
These findings reframe how we understand age-related wound healing failure. The problem is not simply an excess of chronic senescent cells (a well-known aging hallmark), but a specific failure to generate the acute, transient, pro-reparative senescent fibroblasts that young tissue depends on. Aging imposes both a quantitative deficit (fewer beneficial senescent cells) and a qualitative shift (remaining cells adopt a pro-inflammatory rather than ECM-remodeling identity). This dual dysfunction provides a mechanistic basis for therapeutic strategies targeting senescence induction or functional restoration in aged wounds, rather than blanket senolytic clearance.
Key Findings
- Aged (24-month) mice showed significantly delayed full-thickness wound closure vs. young (2-month) mice across all timepoints (days 6–24), confirmed by digital imaging and ImageJ quantification.
- Transient upregulation of p16, p21, p53, and SA-β-galactosidase peaked at day 6 in young wounds and resolved by day 18–24; this response was markedly attenuated in aged wound tissue at the mRNA, protein, and histological levels.
- SASP factors IL-6, MCP-1, MMP-3, MMP-8, MMP-9, TNF, and TGF-β1 were transiently elevated in young wounds but significantly blunted in aged wounds, confirmed by qPCR, Western blot, and ELISA.
- scRNA-seq of day-6 wounds identified a distinct p16+/p21+/Ki67− senescent fibroblast cluster in young mice enriched for ECM organization, collagen fibril assembly, and wound healing gene sets (GSEA FDR < 0.05).
- In aged wounds, this pro-reparative senescent fibroblast population was numerically reduced, and remaining senescent cells showed a qualitative shift toward pro-inflammatory pathway enrichment rather than ECM remodeling.
- Collagen gene expression (Col1a1, Col1a2, Col3a1) was significantly lower in aged wound tissue, consistent with the loss of ECM-remodeling senescent fibroblast function.
- Human scRNA-seq data (GSE241132, young donors) corroborated the existence of a p16+/p21+/Ki67− pro-healing senescent fibroblast population in human wound tissue, supporting cross-species translational relevance.
Methodology
Full-thickness 1-cm excisional dorsal wounds were created in young (2-month) and aged (24-month) male C57BL/6 mice (≥5 animals per group per timepoint: days 6, 12, 18, 24). Outcomes included wound area measurement, qPCR, Western blotting, ELISA, immunostaining (p16, p21, SA-β-gal), and 10x Genomics scRNA-seq of pooled day-6 wound cells (n=3 per age group), processed with Seurat v5.3.0, Harmony batch correction, and CellChat intercellular signaling analysis. Human validation used publicly available scRNA-seq data (GSE241132). Statistical analysis employed two-way ANOVA with post hoc multiple comparisons and two-tailed unpaired t-tests; p<0.05 was the significance threshold.
Study Limitations
The study used only male mice, limiting generalizability to female aging biology and wound healing. The scRNA-seq experiment used pooled cells from n=3 mice per age group, which reduces statistical power for detecting rare cell populations and precludes individual-level variability analysis. The authors did not perform functional rescue experiments (e.g., transplanting young senescent fibroblasts into aged wounds) to directly confirm causality, and the human data relied on a publicly available dataset from young donors only, without aged human wound tissue for direct comparison.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.